Press Releases
Mar. 16, 2026
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
Indeterminate
GlobeNewswire, Inc.
Feb. 26, 2026
16.91% CAGR Puts RTLS in Healthcare Market at the Center of Hospital Digital Transformation
Indeterminate
GlobeNewswire, Inc.
Feb. 26, 2026
Dental Practice Management Software Market on an 8.64% CAGR Path as Clinics Embrace Smarter Systems
Indeterminate
GlobeNewswire, Inc.
Feb. 17, 2026
Why Corporate Wellness Is a Must-Invest Market Now: USD 138.37 Bn Growth Reshaping Workplace Health
Indeterminate
GlobeNewswire, Inc.
Mar. 10, 2026
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Mar. 10, 2026
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Mar. 10, 2026
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Mar. 10, 2026
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Mar. 4, 2026
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Mar. 5, 2026
Oculis to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire, Inc.
Mar. 10, 2026
Distinctive Characteristics of Japan’s Arctic Approach and Engagement with Arctic Governance
Indeterminate
The Arctic Institute
Owner: The Arctic Institute (Non-profit)
Mar. 3, 2026
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
Indeterminate
GlobeNewswire, Inc.
Feb. 17, 2026
Why the Radiopharmaceutical CDMO Market is a Smart Investment: USD 8.50 Bn by 2035
Indeterminate
GlobeNewswire, Inc.
Mar. 2, 2026
SpotSee and Controlant Announce Strategic Collaboration to Expand Shipment Visibility and Last-Mile Proof for Life Sciences
Indeterminate
GlobeNewswire, Inc.
Feb. 18, 2026
Fitness App Market is making hearts stronger and minds lighter on a 45.45B journey by 2035
Indeterminate
GlobeNewswire, Inc.
Feb. 16, 2026
Bioengineering Market Size Worth USD 1,484.98 Billion by 2035 Driven by AI-Powered Drug Discovery and Gene Editing
Indeterminate
GlobeNewswire, Inc.